Unravel

Hardware and health is a combination that makes most investors hesitate, long development cycles, regulatory paths, and the constant question of whether the science actually works. The challenge was building a story where the technology doesn't overshadow the market opportunity. Investors needed to see the clinical value and the consumer behavior shift first, then the device as the unlock, not the other way around.